abagovomab 28
abciximab 24
abituzumab 12
abrilumab 12
actoxumab 14
adalimumab 9
aducanumab 9
afasevikumab 3
alacizumab_pegol 6
alemtuzumab 27
alirocumab 14
amatuximab 29
andecaliximab 17
anifrolumab 18
anrukinzumab 13
aprutumab 10
aprutumab_ixadotin 10
arcitumomab 13
ascrinvacumab 0
atezolizumab 10
atinumab 12
avelumab 10
basiliximab 24
bavituximab 17
begelomab 15
benralizumab 19
bevacizumab_beta 16
bezlotoxumab 14
bimagrumab 10
bleselumab 14
blinatumomab 27
blosozumab 25
bococizumab 18
brazikumab 14
brentuximab_vedotin 18
briakinumab 14
brodalumab 10
brolucizumab 19
brontictuzumab 22
burosumab 17
cabiralizumab 22
camrelizumab 14
canakinumab 18
cantuzumab_ravtansin 29
carlumab 13
carotuximab 8
cergutuzumab_amunaleukin2 25
cergutuzumab_amunaleukin 25
certolizumab_pegol 22
cetiximab 28
citatuzumab_bogatox 24
cixutumumab 20
clivatuzumab_tetraxetan 11
codrituzumab 19
conatumumab 10
concizumab 14
crenezumab 14
crizanlizumab 17
crotedumab 17
dacetuzumab 21
daclizumab 9
dalotuzumab 18
dapirolizumab_pegol 25
daratumumab 11
dectrekumab 7
demcizumab 23
denosumab 7
depatuxizumab 14
depatuxizumab_mafodotin 14
dezamizumab 14
dinutuximab 26
diridavumab 11
domagrozumab 11
drozitumab 17
duligotuzumab 20
durvalumab 13
dusigitumab 23
efalizumab 33
efungumab 17
eldelumab 15
elezanumab 15
elgemtumab 4
elotuzumab 14
emactuzumab 15
emapalumab 18
emibetuzumab 19
enavatuzumab 23
enfortumab_vedotin 10
enoblituzumab 17
enokizumab 20
enoticumab 17
ensituximab 24
eptinezumab 9
erenumab 19
etaracizumab 12
etrolizumab 19
evinacumab 16
evolocumab 14
farletuzumab 0
fasinumab 20
fezakinumab 14
fibatuzumab 6
ficlatuzumab 24
firivumab 25
flanvotumab 14
fletikumab 25
foralumab 13
foravirumab 14
fremanezumab 24
fresolimumab 10
fulranumab 15
futuximab 10
galcanezumab 10
ganitumab 15
gantenerumab 13
gemetuzumab 25
gemtuzumab2 23
gemtuzumab 12
gevokizumab 15
girentuximab 22
glembatumumab 15
glembatumumab_vedotin 15
guselkumab 14
ibalizumab 22
ibritumomab 22
icrucumab 14
idarucizumab 24
ifabotuzumab 6
imalumab 11
imgatuzumab 18
inclacumab 14
indatuximab_ravtansin 27
indusatumab 16
inebilizumab 17
intetumumab 11
iodine_girentuximab 20
ipilimumab 4
iratumumab 11
isatuximab 25
itolizumab 17
ixekizumab 20
labetuzumab_govitecan 23
lambrolizumab 24
lampalizumab 23
lanadelumab 16
landogrozumab 13
laprituximab 24
lebrikizumab 23
lendalizumab 23
lenzilumab 15
lifastuzumab_vedotin 15
ligelizumab 13
lilotomab 30
lirilumab 19
lodelcizumab 13
lokivetmab 11
lorvotuzumab_mertansin 14
lucatumumab 26
lumretuzumab 16
lupartumab 13
lutikizumab 12
margetuximab 29
milatuzumab 18
mirvetuximab 32
mirvetuximab_soravtansin 32
modotuximab 31
mogamulizumab 17
monalizumab 21
motavizumab 27
moxetumomab_pasudotox 14
namilumab 18
naratuximab 26
naratuximab_emtansin 26
narnatumab 15
navicixizumab2 26
navicixizumab 23
navivumab 14
necitumumab 7
nemolizumab 22
nesvacumab 14
nivolumab 14
obiltoxaximab 15
obinutuzumab 24
ocaratuzumab 14
ofatumumab 12
olaratumab 11
olokizumab 19
omalizumab 16
onartuzumab 22
ontuxizumab 18
opicinumab 13
orticumab 6
otelixizumab 25
oxelumab 8
ozanezumab 17
pamrevlumab 7
panobacumab 18
parsatuzumab 27
pasotuxizumab 16
pateclizumab 15
patritumab 15
pembrolizumab 24
perakizumab 19
pidilizumab 13
pinatuzumab_vedotin 11
plozalizumab 13
pogalizumab 22
polatuzumab_vedotin 17
ponezumab 21
prezalumab 14
pritoxaximab 27
quilizumab 15
racotumomab 22
radretumab 10
ralpancizumab 23
ramucirumab 8
ranevetmab 29
ranibizumab 13
refanezumab 17
remtolumab 10
rilotumumab 14
rinucumab 4
risankizumab 27
rituximab 9
rivabazumab 22
robatumumab 18
roledumab 17
romosozumab 17
rontalizumab 22
rosmantuzumab 13
rozanolixizumab 18
sacituzumab 25
sacituzumab_govitecan 25
samalizumab 21
sapelizumab 18
sarilumab 9
secukinumab 15
seribantumab 16
setoxaximab 29
sifalimumab 10
siltuximab 7
simtuzumab 25
sirukumab 9
solanezumab 22
solitomab 22
stamulumab 16
suptavumab 20
suvizumab 13
tabalumab 8
tadocizumab 11
tamtuvetmab 26
tanezumab 19
tarextumab 9
tavolixizumab 8
telisotuzumab 24
teplizumab 15
tesidolumab 20
tezepelumab 25
tigatuzumab 13
tildrakizumab 16
timolumab 11
tisotumab 9
tosatoxumab 23
tositumomab 19
tralokinumab 25
trastuzumab 24
tregalizumab 18
trevogrumab 8
ublituximab 18
urelumab 13
ustekinumab 22
utomilumab 19
vadastuximab 15
vadastuximab_talirin 15
vandortuzumab_vedotin 17
vantictumab 23
vanucizumab2 16
vanucizumab 21
varlilumab 18
vatelizumab 11
vedolizumab 11
veltuzumab 8
vesencumab 7
vorsetuzumab 21
vorsetuzumab_mafodotin 21
vunakizumab 28
xentuzumab 17
zatuximab 31
